Please login to the form below

Not currently logged in
Email:
Password:

dimethyl glutamate

This page shows the latest dimethyl glutamate news and features for those working in and with pharma, biotech and healthcare.

Merck gets CHMP backing for long-delayed oral MS drug

Merck gets CHMP backing for long-delayed oral MS drug

competitive landscape" - with oral therapies such as Novartis' Gilenya (fingolimod) and Biogen's Tecfidera (dimethyl glutamate) reaching or near the market.

Latest news

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics